Cellworks Stock
Cellworks is a life sciences technology company involved in drug and bio-marker discovery and researches in therapeutic areas.
Sign up today and learn more about Cellworks Stock
Invest in or value your shares in one or many pre-IPO companies through an EquityZen investment vehicle.
About Cellworks Stock
Cellworks Group, Inc. operates as a life sciences technology company. The company provides iC-PHYS, a technology platform that enables drug and bio-marker discovery and research in focused therapeutic areas. The company provides disease focused drug discovery and research solutions in the areas of oncology, such as integrated tumor cell and endothelial cell with stromal inputs; inflammation diseases, such as macrophage, neutrophil, osteoclast, and T-cell; type-2 diabetes; infectious diseases; skin pigmentation and ageing; and neurodegenerative. The company was founded in 2005 and is based in Saratoga, California. It has a research and development facility in Bangalore, India.
Funding History
| April 2009 | $3.5M |
|---|---|
| March 2012 | $1.0M |
| December 2012 | $13.0M |
Management
Co-Founder & Chief Scientific Officer
Shireen Vali
Co-Founder & CEO
Taher Abbasi
Co-Founder & President
Pradeep Fernandes
Press
TechCrunch - Sep, 15 2015
The Best Things Come In ThreesEquityZen does not have an affiliation with, formal relationship with, or endorsement from any companies featured above. This profile is based on publicly available information and is intended to be informative in nature.
Some data provided by Crunchbase
EquityZen Recognized As:
